62 related articles for article (PubMed ID: 38448914)
1. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development.
Zhao HF; Wang J; Shao W; Wu CP; Chen ZP; To ST; Li WP
Mol Cancer; 2017 Jun; 16(1):100. PubMed ID: 28592260
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
[TBL] [Abstract][Full Text] [Related]
3. CD133 significance in glioblastoma development: in silico and in vitro study.
Abdoli Shadbad M; Nejadi Orang F; Baradaran B
Eur J Med Res; 2024 Mar; 29(1):154. PubMed ID: 38448914
[TBL] [Abstract][Full Text] [Related]
4. hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma: in-silico and in-vitro study.
Abdoli Shadbad M; Baghbanzadeh A; Baradaran B
EXCLI J; 2024; 23():384-400. PubMed ID: 38655096
[TBL] [Abstract][Full Text] [Related]
5. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
[TBL] [Abstract][Full Text] [Related]
6. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
7. Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p.
Fu T; Yang Y; Mu Z; Sun R; Li X; Dong J
Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):680-692. PubMed ID: 34435542
[TBL] [Abstract][Full Text] [Related]
8. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
[TBL] [Abstract][Full Text] [Related]
9. Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis.
Tuo Z; Feng D; Jiang Z; Bi L; Yang C; Wang Q
Chin J Cancer Res; 2023 Dec; 35(6):686-701. PubMed ID: 38204439
[TBL] [Abstract][Full Text] [Related]
10. AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification.
Wang H; Liu J; Zhu X; Yang B; He Z; Yao X
Research (Wash D C); 2023; 6():0252. PubMed ID: 37854295
[TBL] [Abstract][Full Text] [Related]
11. Unimolecular Self-Assembled Hemicyanine-Oleic Acid Conjugate Acts as a Novel Succinate Dehydrogenase Inhibitor to Amplify Photodynamic Therapy and Eliminate Cancer Stem Cells.
Wang Q; Yang T; Li S; Xu C; Wang C; Xiong Y; Wang X; Wan J; Yang X; Li Z
Research (Wash D C); 2023; 6():0223. PubMed ID: 37680304
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects.
Pineda E; Domenech M; Hernández A; Comas S; Balaña C
Onco Targets Ther; 2023; 16():71-86. PubMed ID: 36721854
[TBL] [Abstract][Full Text] [Related]
13. Drug toxicity assessment: cell proliferation versus cell death.
Sazonova EV; Chesnokov MS; Zhivotovsky B; Kopeina GS
Cell Death Discov; 2022 Oct; 8(1):417. PubMed ID: 36241623
[TBL] [Abstract][Full Text] [Related]
14. Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives.
Guo QL; Dai XL; Yin MY; Cheng HW; Qian HS; Wang H; Zhu DM; Wang XW
Mil Med Res; 2022 Jun; 9(1):26. PubMed ID: 35676737
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Glioblastoma Multiforme-Literature Review.
Grochans S; Cybulska AM; Simińska D; Korbecki J; Kojder K; Chlubek D; Baranowska-Bosiacka I
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626018
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
